Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Induction therapy for stage III NSCLC: a consensus report.
Green MR, Ginsberg R, Ardizzoni A, Choi N, Darwish S, Fukuoka M, Giner V, Grunenwald D, Harper P, Kho S, et al. Green MR, et al. Among authors: ginsberg r. Lung Cancer. 1994 Nov;11 Suppl 3:S9-10. doi: 10.1016/0169-5002(94)91858-9. Lung Cancer. 1994. PMID: 7704518 Review. No abstract available.
Prognostic factors in non-small cell lung cancer.
Feld R, Borges M, Giner V, Ginsberg R, Harper P, Klastersky J, Lacquet L, Paesmans M, Payne D, Rosell R, et al. Feld R, et al. Among authors: ginsberg r. Lung Cancer. 1994 Nov;11 Suppl 3:S19-23. doi: 10.1016/0169-5002(94)91861-9. Lung Cancer. 1994. PMID: 7704508 Review. No abstract available.
Pre-operative and post-operative treatments in stage III NSCLC.
Green M, Brodin O, Choi N, Drings P, Ginsberg R, Gralla R, Johnson D, Mulshine J, Payne D, Ruffié P. Green M, et al. Among authors: ginsberg r. Lung Cancer. 1994 Mar;10 Suppl 1:S15-7. doi: 10.1016/0169-5002(94)91662-4. Lung Cancer. 1994. PMID: 8087504 No abstract available.
Staging classification committee.
Ginsberg R, Cox J, Green M, Bulzebruck H, Grunenwald D, Harper P, Jett J, LeChevalier T, Mornex F, Scott C, Tsuchiya R. Ginsberg R, et al. Lung Cancer. 1997 Jun;17 Suppl 1:S11-3. doi: 10.1016/s0169-5002(97)00037-8. Lung Cancer. 1997. PMID: 9213296 Review. No abstract available.
[The International Association for the Study of Lung Cancer Staging Project. Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer].
Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P; International Staging Committee and Participating Institutions. Chansky K, et al. Zhongguo Fei Ai Za Zhi. 2010 Jan;13(1):9-18. doi: 10.3779/j.issn.1009-3419.2010.01.02. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20672697 Free PMC article. Chinese.
Effectiveness and toxicity of preoperative therapy in stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2).
Kris MG, Pisters KM, Ginsberg RJ, Rigas JR, Miller VA, Grant SC, Gralla RJ, Heelan RT, Martini N. Kris MG, et al. Among authors: ginsberg rj. Lung Cancer. 1995 Apr;12 Suppl 1:S47-57. doi: 10.1016/0169-5002(95)00420-6. Lung Cancer. 1995. PMID: 7551934 Free article. Review.
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial.
Burkes RL, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, Patterson GA, Todd T, Pearson FG, Jones D, Farooq S, McGlaughlin J, Ginsberg RJ. Burkes RL, et al. Lung Cancer. 2005 Jan;47(1):103-9. doi: 10.1016/j.lungcan.2004.06.004. Lung Cancer. 2005. PMID: 15603860 Clinical Trial.
284 results